Neoadjuvant treatment of esophageal cancer
- PMID: 20698042
- PMCID: PMC2921091
- DOI: 10.3748/wjg.v16.i30.3793
Neoadjuvant treatment of esophageal cancer
Abstract
The management of esophageal cancer has been evolving over the past 30 years. In the United States, multimodality treatment combining chemotherapy and radiotherapy (RT) prior to surgical resection has come to be accepted by many as the standard of care, although debate about its overall effect on survival still exists, and rightfully so. Despite recent improvements in detection and treatment, the overall survival of patients with esophageal cancer remains lower than most solid tumors, which highlights why further advances are so desperately needed. The aim of this article is to provide a complete review of the history of esophageal cancer treatment with the addition of chemotherapy, RT, and more recently, _targeted agents to the surgical management of resectable disease.
Similar articles
-
Who profits from neoadjuvant radiochemotherapy for locally advanced esophageal carcinoma?J Gastroenterol Hepatol. 2009 May;24(5):708-10. doi: 10.1111/j.1440-1746.2009.05838.x. J Gastroenterol Hepatol. 2009. PMID: 19646012 No abstract available.
-
Neoadjuvant therapy for advanced esophageal cancer: the impact on surgical management.Gen Thorac Cardiovasc Surg. 2016 Jul;64(7):386-94. doi: 10.1007/s11748-016-0655-y. Epub 2016 May 10. Gen Thorac Cardiovasc Surg. 2016. PMID: 27165288 Review.
-
Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer.Ann Thorac Surg. 2008 Apr;85(4):1217-23; discussion 1223-4. doi: 10.1016/j.athoracsur.2007.11.070. Ann Thorac Surg. 2008. PMID: 18355499
-
Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or gastroesophageal junction: long-term results of a randomized clinical trial.Dis Esophagus. 2019 Feb 1;32(2). doi: 10.1093/dote/doy078. Dis Esophagus. 2019. PMID: 30137281 Clinical Trial.
-
The multidisciplinary management of gastrointestinal cancer. Multimodal treatment of oesophageal cancer.Best Pract Res Clin Gastroenterol. 2007;21(6):947-63. doi: 10.1016/j.bpg.2007.10.005. Best Pract Res Clin Gastroenterol. 2007. PMID: 18070697 Review.
Cited by
-
MicroRNA and its roles in esophageal cancer.Med Sci Monit. 2012 Mar;18(3):RA22-30. doi: 10.12659/msm.882509. Med Sci Monit. 2012. PMID: 22367141 Free PMC article. Review.
-
EGFR-_targeted Immunotoxin Exerts Antitumor Effects on Esophageal Cancers by Increasing ROS Accumulation and Inducing Apoptosis via Inhibition of the Nrf2-Keap1 Pathway.J Immunol Res. 2018 Nov 25;2018:1090287. doi: 10.1155/2018/1090287. eCollection 2018. J Immunol Res. 2018. PMID: 30596104 Free PMC article.
-
Epidermal growth factor receptor protein overexpression and gene amplification are associated with aggressive biological behaviors of esophageal squamous cell carcinoma.Oncol Lett. 2015 Aug;10(2):901-906. doi: 10.3892/ol.2015.3277. Epub 2015 May 27. Oncol Lett. 2015. PMID: 26622592 Free PMC article.
-
JmjC-KDMs KDM3A and KDM6B modulate radioresistance under hypoxic conditions in esophageal squamous cell carcinoma.Cell Death Dis. 2020 Dec 14;11(12):1068. doi: 10.1038/s41419-020-03279-y. Cell Death Dis. 2020. PMID: 33318475 Free PMC article.
-
Prognostic value of inflammatory markers for detecting anastomotic leakage after esophageal resection.BMC Surg. 2020 Dec 9;20(1):324. doi: 10.1186/s12893-020-00995-2. BMC Surg. 2020. PMID: 33298038 Free PMC article.
References
-
- Bollschweiler E, Wolfgarten E, Gutschow C, Hölscher AH. Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer. 2001;92:549–555. - PubMed
-
- Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst. 2005;97:142–146. - PubMed
-
- Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24:2137–2150. - PubMed
-
- Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225–249. - PubMed
-
- Eslick GD. Epidemiology of esophageal cancer. Gastroenterol Clin North Am. 2009;38:17–25, vii. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous